Showing results (211-220 of 300) with videos related to

Sort By:
Pageof 30
Journal of Alzheimer'S Disease : JAD|August 14, 2022
DTI Connectometry Analysis Reveals White Matter Changes in Cognitively Impaired World Trade Center Responders at MidlifeMinos Kritikos, Chuan Huang, Sean A P Clouston, et al.
Neurotrauma Reports|December 13, 2021
Transcranial Laser Therapy Does Not Improve Cognitive and Post-Traumatic Stress Disorder-Related Behavioral Traits in Rats Exposed to Repetitive Low-Level Blast InjuryGeorgina Perez Garcia, Gissel M Perez, Alena Otero-Pagan, et al.
Acta Neuropathologica|June 15, 2017
Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathologyJean-Vianney Haure-Mirande, Mickael Audrain, Tomas Fanutza, et al.
Journal of Neurotrauma|October 29, 2020
Progressive Cognitive and Post-Traumatic Stress Disorder-Related Behavioral Traits in Rats Exposed to Repetitive Low-Level BlastGeorgina Perez Garcia, Gissel M Perez, Rita De Gasperi, et al.
ACS Chemical Biology|March 26, 2013
Evidence for age-dependent in vivo conformational rearrangement within Aβ amyloid depositsSofie Nyström, Katarzyna M Psonka-Antonczyk, Pål Gunnar Ellingsen, et al.
World Journal of Nuclear Medicine|November 18, 2022
Assessment of Alzheimer's Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at MidlifeMinos Kritikos, Ana M Franceschi, Paul Vaska, et al.
Molecular Neurodegeneration|October 27, 2009
Novel cerebrovascular pathology in mice fed a high cholesterol dietSonia Franciosi, Miguel A Gama Sosa, Daniel F English, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
Ayahuasca: A review of historical, pharmacological, and therapeutic aspectsSimon G D Ruffell, Max Crosland-Wood, Rob Palmer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 5, 2021
Selective hippocampal subfield volume reductions in World Trade Center responders with cognitive impairmentYael Deri, Sean A P Clouston, Christine DeLorenzo, et al.
Molecular Cancer Therapeutics|April 8, 2011
Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trialMonika E Hegi, Annie-Claire Diserens, Pierre Bady, et al.
Pageof 30